BioCentury | Oct 6, 2014
Clinical News

Algisyl-LVR regulatory update

...LoneStar Heart said it received CE Mark approval for its Algisyl-LVR hydrogel implant to treat advanced...
...muscle and acts as an internal scaffold. LoneStar Heart Inc. , Laguna Hills, Calif. Product: Algisyl-LVR...
BioCentury | Mar 6, 2014
Tools & Techniques

Taking TIMP3 to heart

...the MI-associated inflammation. Data were published in Science Translational Medicine . LoneStar Heart Inc. has Algisyl-LVR...
BioCentury | Oct 10, 2012
Top Story

LoneStar announces series B extension

...close of the B round in September 2011. Themes' Frank Yu joined LoneStar's Board. LoneStar's Algisyl-LVR...
...the walls of the heart. LoneStar said it plans to seek CE Mark approval for Algisyl-LVR...
BioCentury | Jun 25, 2012
Emerging Company Profile

LoneStar Heart: Straight to the heart

...40-60% of patients die within five years of diagnosis, Ahmann told BioCentury. LoneStar's lead program, Algisyl-LVR...
...as a prosthetic matrix, reducing muscle tension and stress along the walls of the heart. Algisyl-LVR...
...meeting in September and start a pilot efficacy study before year end. LoneStar is developing Algisyl-LVR...
BioCentury | Jan 30, 2012
Company News

LoneStar Heart, University of Texas Southwestern Medical Center deal

...progenitor cells in the heart to become cardiac muscle cells. LoneStar's lead product candidate is Algisyl-LVR...
Items per page:
1 - 5 of 5